(Q55473298)

12 July 2018

title

Immunohistochemical markers for prognosis of anaplastic astrocytomas. (English)

1 reference

12 July 2018

1 reference

1

Andrey Korshunov

1 reference

12 July 2018

author name string

Andrey Golanov

series ordinal

2

1 reference

12 July 2018

Regina Sycheva

series ordinal

3

1 reference

12 July 2018

publication date

1 July 2002

1 reference

12 July 2018

Journal of Neuro-Oncology

published in

1 reference

12 July 2018

volume

58

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

page(s)

203-215

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1023/a:1016261900413

exact match

0 references

cites work

Grading of astrocytomas. A simple and reproducible method.

1 reference

12 December 2020

Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas

1 reference

12 December 2020

5-year survival and clinical prognostic factors in progressive supratentorial diffuse "low-grade" astrocytoma: a retrospective analysis of 46 cases.

1 reference

12 December 2020

p27/kip1 expression in human astrocytic gliomas.

1 reference

12 December 2020

Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression.

1 reference

12 December 2020

Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.

1 reference

12 December 2020

Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.

1 reference

12 December 2020

Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications

1 reference

12 December 2020

Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma.

1 reference

12 December 2020

p27Kip1 expression by contact inhibition as a prognostic index of human glioma.

1 reference

12 December 2020

Prognostic implications of p53 overexpression in supratentorial astrocytic tumors.

1 reference

12 December 2020

Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.

1 reference

12 December 2020

MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor

1 reference

12 December 2020

PTEN gene mutations are seen in high-grade but not in low-grade gliomas.

1 reference

12 December 2020

Prognostic significance of p53 immunoreactivity in adult patients with supratentorial fibrillary astrocytic neoplasms.

1 reference

12 December 2020

Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas.

1 reference

12 December 2020

Analysis of 2 antiapoptotic factors in gliomas: bcl-2 overexpression and p53 mutations.

1 reference

12 December 2020

Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas

1 reference

12 December 2020

Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors.

1 reference

12 December 2020

Malignant glioma: genetics and biology of a grave matter.

1 reference

12 December 2020

Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival.

1 reference

12 December 2020

Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival

1 reference

12 December 2020

Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity

1 reference

12 December 2020

CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.

1 reference

12 December 2020

DNA topoisomerase II-alpha as a proliferation marker in astrocytic neoplasms of the central nervous system: correlation with MIB1 expression and patient survival.

1 reference

12 December 2020

Proliferating cell nuclear antigen expression in the survival of astrocytoma patients.

1 reference

12 December 2020

Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.

1 reference

12 December 2020

Mitosis identification in diffuse gliomas: implications for tumor grading

1 reference

12 December 2020

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

1 reference

12 December 2020

Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival.

1 reference

12 December 2020

Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples

1 reference

12 December 2020

Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis.

1 reference

12 December 2020

Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes.

1 reference

12 December 2020

Real-time quantification of the proliferative state in astrocytomas.

1 reference

12 December 2020

Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas.

1 reference

12 December 2020

Immunohistochemical analysis of cyclin A in astrocytic tumours.

1 reference

12 December 2020

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

1 reference

12 December 2020

Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival.

1 reference

12 December 2020

Analysis of cyclin dependent kinase inhibitors in malignant astrocytomas.

1 reference

12 December 2020

p53 immunoreactivity in astrocytomas and its relationship to survival.

1 reference

12 December 2020

Proliferating cell nuclear antigen immunostaining and survival in cerebral astrocytoma.

1 reference

12 December 2020

Loss of DCC expression in astrocytomas: relation to p53 abnormalities, cell kinetics, and survival

1 reference

12 December 2020

Correlation of p53 immunoreactivity and sequencing in patients with glioma.

1 reference

12 December 2020

Supratentorial gliomas: a comparative study by grade and histologic type.

1 reference

12 December 2020

Comparison of cyclin A and MIB-1 expression in astrocytic tumors using image-based cell analysis system.

1 reference

12 December 2020

p53 immunohistochemical positivity as a prognostic marker in intracranial tumours.

1 reference

12 December 2020

Prognostic factors in gliomas. A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers

1 reference

12 December 2020

Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.

1 reference

12 December 2020

High cyclin E/low p27Kip1 expression is associated with poor prognosis in astrocytomas.

1 reference

12 December 2020

Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms

1 reference

12 December 2020

Genetic sub-types of human malignant astrocytoma correlate with survival.

1 reference

12 December 2020

Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases

1 reference

12 December 2020

Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value.

1 reference

12 December 2020

Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations.

1 reference

12 December 2020

Long-term survival in treated anaplastic astrocytomas. A report of combined RTOG/ECOG studies

1 reference

12 December 2020

Extent of resection as a prognostic variable in the treatment of gliomas

1 reference

12 December 2020

Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma.

1 reference

12 December 2020

Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value

1 reference

12 December 2020

Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.

1 reference

12 December 2020

Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma

1 reference

12 December 2020

The challenge of p53 as prognostic and predictive factor in gliomas

1 reference

12 December 2020

Cellular proliferation in pilocytic and diffuse astrocytomas.

1 reference

12 December 2020

Correlation of histopathological features and proliferative potential of gliomas.

1 reference

12 December 2020

Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival.

1 reference

12 December 2020

A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.

1 reference

12 December 2020

Overexpression of cyclin A and cyclin B1 proteins in astrocytomas.

1 reference

12 December 2020

Relationship between Ki-67 labeling index and survival in high-grade glioma patients treated after surgery with tamoxifen.

1 reference

12 December 2020

p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers

1 reference

12 December 2020

Long-term survival in patients with malignant astrocytoma.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1016261900413

1 reference

12 July 2018

Dimensions Publication ID

0 references

1 reference

12 July 2018